Five-year results of a treatment program for chronic hepatitis B in Ethiopia

BACKGROUND: In sub-Saharan Africa, less than 1% of treatment-eligible chronic hepatitis B (CHB) patients receive antiviral therapy. Experiences from local CHB programs are needed to inform treatment guidelines and policies on the continent. Here, we present 5-year results from one of the first large...

Descripción completa

Detalles Bibliográficos
Autores principales: Desalegn, Hailemichael, Orlien, Stian Magnus Staurung, Aberra, Hanna, Mamo, Eyerusalem, Grude, Sine, Hommersand, Kristina, Berhe, Nega, Gundersen, Svein Gunnar, Johannessen, Asgeir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543851/
https://www.ncbi.nlm.nih.gov/pubmed/37775742
http://dx.doi.org/10.1186/s12916-023-03082-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543851/
https://www.ncbi.nlm.nih.gov/pubmed/37775742
http://dx.doi.org/10.1186/s12916-023-03082-4

Ejemplares similares